STATINS AND MYOPATHY: MOLECULAR MECHANISMS
The safety of statin therapy is considered. In particular the reasons of a complication such as myopathy are discussed in detail. The molecular mechanisms of statin myopathy , as well as its risk factors are presented. The role of coenzyme Q10 in the myopathy development and coenzyme Q10 application...
Saved in:
Main Authors: | O. M. Drapkina, E. M. Chernova, O. N. Korneeva |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-12-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/472 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT
by: O. M. Drapkina, et al.
Published: (2015-09-01) -
Statin-Induced Myopathy
by: D. A. Sychev, et al.
Published: (2023-09-01) -
Two Cases of Statin-Induced Immune-Mediated Necrotizing Myopathy: A Rare Side Effect of Statins
by: Luis Angel Montero Furelos, et al.
Published: (2025-06-01) -
MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS
by: A. S. Kazakov, et al.
Published: (2018-09-01) -
New experimental possibilities for statin myopathy diagnosing
by: E. V. Vinogradova, et al.
Published: (2021-07-01)